Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Revenue | 121M | 125M | 123M | 120M | 119M | 116M |
| Cost of revenue | 19M | 18M | 19M | 19M | 20M | 20M |
| Gross profit | 102M | 106M | 104M | 101M | 99M | 96M |
| Research and development | 30M | 29M | 31M | 34M | 34M | 35M |
| Selling, general and administrative | 23M | 24M | 25M | 27M | 25M | 26M |
| Operating expenses | 93M | 98M | 101M | 111M | 109M | 112M |
| Operating income | 9M | 8M | 4M | −10M | −10M | −16M |
| Interest expense | — | — | — | — | — | 2M |
| Pre-tax income | 11M | 12M | 8M | −7M | −5M | −11M |
| Income tax | 6M | −150M | −2M | 813,000 | 715,000 | 427,000 |
| Net income | 5M | 162M | 10M | −7M | −6M | −11M |
| Earnings per share | 0.13 | 1.72 | 0.11 | −0.07 | −0.07 | −0.14 |
| Earnings per share, diluted | 0.13 | 1.69 | 0.10 | −0.07 | −0.07 | −0.14 |
| Weighted average shares | 79M | 93M | 93M | 91M | 91M | 93M |
| Weighted average shares, diluted | 79M | 95M | 94M | 91M | 91M | 93M |
| Metric | 30/04/2026 | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 209M | 237M | 324M | 340M | 372M | 346M | 326M | 386M |
| Short-term investments | 235M | 232M | 224M |
| Metric | 30/04/2026 | 30/04/2025 |
|---|---|---|
| Operating cash flow | 44M | 31M |
| Depreciation and amortisation | 3M | 4M |
| Share-based compensation | 18M | 26M |
| Capital expenditure | 965,000 | 441,000 |
| Investing cash flow | −5M | −2M |
| Share buybacks | 65M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 228M |
| 225M |
| 224M |
| 216M |
| 214M |
| Receivables | 76M | 108M | 79M | 70M | 80M | 107M | 75M | 67M |
| Current assets | 559M | 612M | 659M | 672M | 713M | 712M | 654M | 700M |
| Property, plant and equipment | 32M | 29M | 27M | 25M | 22M | 21M | 20M | 18M |
| Goodwill | 137M | 137M | 137M | 137M | 137M | 137M | 137M | 137M |
| Total assets | 937M | 991M | 1.03B | 892M | 927M | 927M | 867M | 916M |
| Current liabilities | 287M | 304M | 278M | 281M | 354M | 369M | 332M | 329M |
| Total liabilities | 708M | 720M | 688M | 694M | 764M | 779M | 739M | 735M |
| Equity | 217M | 254M | 320M | 181M | 146M | 130M | 112M | 165M |
| Shares outstanding | — | — | — | — | — | 91M | — | — |
| 0 |
| Financing cash flow | −68M | −4M |